Search results
Gilead's HIV prevention trial shows promise with zero infections By Investing.com
Investing.com· 3 days agoGilead Sciences, Inc. (NASDAQ:GILD) has reported that its Phase 3 trial of an injectable HIV...
Twice-yearly shots of Gilead HIV drug effective in large prevention study
BioPharma Dive via Yahoo Finance· 3 days agoDive Brief: Twice-yearly shots of a Gilead Sciences HIV drug were so effective at preventing...
Forty years ago, AIDS was a death sentence. Not today, but HIV is still a health threat
Gannett via AOL· 4 days agoIt’s not shocking or even surprising that HIV and AIDS are on the rise in today’s world. The dreaded...
Federal appeals court says some employers can exclude HIV prep from insurance coverage
Dayton Daily News· 17 hours agoNEW ORLEANS (AP) — Employers who challenged some federal health insurance requirements cannot be...
Health Department selects organization for HIV case management in Lewis, Thurston, Mason and Pierce...
The Chronicle, Centralia, Wash. via Yahoo News· 1 day agoOn Thursday, the DOH announced that CCAP and AHF would provide case management services in Lewis, Mason, Pierce...
Data on HIV prevention drug helps stock surge
Detroit Free Press· 20 hours agoToward the end of the trading week, which was shortened by the Juneteenth holiday, profit-taking in chipmaker stocks emerged, tempering the earlier...
Gilead’s Twice-Yearly Shot Prevents HIV. Where the Stock Is Headed.
Barrons.com· 2 days agoFEATURE Gilead Sciences ’ twice-yearly antiviral injection prevented HIV in all of the test subjects...
Appeals court does not block US mandate to cover cancer screenings, HIV drugs
Reuters via AOL· 1 day ago(Reuters) -A U.S. appeals court on Friday refused to block a federal mandate requiring health...
Gilead’s twice-yearly shot prevents 100% of HIV cases in trial with women
Clinical Trials Arena via Yahoo Finance· 3 days agoGilead has announced topline results from an interim analysis of its Phase III PURPOSE 1 trial...
Gilead Shot Prevents All HIV Cases in Trial of African Women
Bloomberg via Yahoo Finance· 3 days ago(Bloomberg) -- Gilead Sciences Inc.’s experimental twice-yearly shot prevented 100% of HIV cases in...